DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
To determine if a vaccine made from patient\'s own tumor tissue can stimulate an immune response against the patient\'s tumor cells. To determine the safety of the vaccine
Epistemonikos ID: 71169d50e911d7776f401fb602e38f0796a0fb21
First added on: May 04, 2024